arrow
L

Larissa J. Vos

university of alberta
H指数:19
被引数:1,348
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

早期乳腺癌患者化疗相关体重增加:一项前瞻性配对队列研究揭示其与炎症及肠道微生态失调的相关性

2023-05-1111
OAAI
Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer
2021-09-0115
PRE
Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study
2021-01-0118
PREAI
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial
2021-01-0120
OAAI
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
2018-05-041
PREAI
Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancereffects of hypoxia

己糖转运蛋白GLUT1,GLUT2和GLUT5在缺氧乳腺癌中的表达和功能

2018-04-1363
PREAI
PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer
2016-10-0132
OAAI
A Phase III Randomized Control Trial Comparing Skin-Sparing Helical Tomotherapy Versus 3D-Conformal Radiation Therapy in Early-Stage Breast Cancer: Acute and Late Skin Toxicity Outcomes
2016-10-010
PREAI
Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer
2016-08-0131
PREAI
Targeting lysyl oxidase for molecular imaging in breast cancer
2015-08-1335
OAAI
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors
2015-03-13118
PREAI
Zwint-1 is a novel Aurora B substrate required for the assembly of a dynein-binding platform on kinetochores
2011-09-1552
OAAI
Stable hZW10 kinetochore residency, mediated by hZwint-1 interaction, is essential for the mitotic checkpoint
2008-02-1174
OAAI